Skip to main content

Advertisement

SpringerLink
Log in

Atrial fibrillation in carcinoid heart disease

The role of Serotonin. A review of the literature

  • CLINICAL CORRESPONDENCE
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brachmann J, Hilbel T, Beyer T, Schols W, Karolyi L, Freigang K, Becker R, Bauer A, Kubler W (1996) New aspects of defibrillator therapy. Z Kardiol 85(Suppl 6):83–89

    PubMed  Google Scholar 

  2. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski P, Nikutta P, Lichtlen PR (1988) Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 11:1204–1211

    PubMed  CAS  Google Scholar 

  3. Denney WD, Kemp WE Jr, Anthony LB, Oates JA, Byrd BF 3rd (1998) Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 32:1017–1022

    Article  PubMed  CAS  Google Scholar 

  4. Hoffmann J, Grimm W, Menz V, Wied M, Funck R, Arnold R, Maisch B (1999) Heart rate variability in carcinoid heart disease. Am J Cardiol 83:128–131, A129

    Article  PubMed  CAS  Google Scholar 

  5. Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R, Maisch B (2001) Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 63:35–42

    Article  PubMed  CAS  Google Scholar 

  6. Horstkotte D, Niehues R, Strauer BE (1991) Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 12(Suppl B):55–60

    PubMed  Google Scholar 

  7. James TN, Isobe JH, Urthaler F (1975) Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 52:179–192

    PubMed  CAS  Google Scholar 

  8. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N (1990) Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 16:377–380

    Article  PubMed  CAS  Google Scholar 

  9. Kuruvilla A, Aiman R (1973) Influence of 5-hydroxytryptamine on experimentally induced atrial arrhythmias in dogs. Indian J Physiol Pharmacol 17:111–116

    PubMed  CAS  Google Scholar 

  10. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E (1988) Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 77:264–269

    PubMed  CAS  Google Scholar 

  11. Madan BR, Khanna NK, Godhwani JL, Pendse VK (1969) Role of 5-hydroxytryptamine in atrial arrhythmias – an experimental study in dogs. Indian J Physiol Pharmacol 13:233–237

    PubMed  CAS  Google Scholar 

  12. Madan BR, Khanna NK, Godhwani JL, Pendse VK (1970) Changes in the 5-hydroxytryptamine (5-HT) content of the heart during ectopic ventricular arrhythmia and consequent to its reversion by quinidine. Indian J Med Res 58:130–134

    PubMed  CAS  Google Scholar 

  13. Mattke S, Dorwarth U, Muller D, Hoffmann E, Markewitz A, Kaulbach H, Schmockel M, Steinbeck G (1994) Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention. Z Kardiol 83:359–365

    PubMed  CAS  Google Scholar 

  14. Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH (1961) Life history of the carcinoid tumor of the small intestine. Cancer 14:901–912

    Article  PubMed  CAS  Google Scholar 

  15. Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, Noble J, Newman D (2003) Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 8:215–220

    Article  PubMed  Google Scholar 

  16. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, Vlahakes GJ, Garan H, Ruskin JN (1995) Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 91:2204–2213

    PubMed  CAS  Google Scholar 

  17. Polster J, Klapdor R, Langenstein BA, Hanrath P (1982) Echocardiographic detection of tricuspid insufficiency in carcinoid heart syndrome – case report. Z Kardiol 71:689–690

    PubMed  CAS  Google Scholar 

  18. Schneider JA, Yonkman FF (1953) Action of serotonin (5-hydroxytryptamine) on vagal afferent impulses in the cat. Am J Physiol 174:127–134

    PubMed  CAS  Google Scholar 

  19. Tornebrandt K, Eskilsson J, Nobin A (1986) Heart involvement in metastatic carcinoid disease. Clin Cardiol 9:13–19

    Article  PubMed  CAS  Google Scholar 

  20. Weatherall M (1968) Drugs and excitable cell membranes. In: Robson JM, Stacey RS (eds) Recent advances in pharmacology. London, Churchill 7, 22

  21. Weber M, Block M, Brunn J, Bansch D, Bocker D, Hammel D, Gietzen F, Breithardt G (1996) Inadequate therapies with implantable cardioverterdefibrillators – incidence, etiology, predictive factors and preventive strategies. Z Kardiol 85:809–819

    PubMed  CAS  Google Scholar 

  22. Yusuf S, Al-Saady N, Camm AJ (2003) 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? J Cardiovasc Electrophysiol 14:209–214

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kardiologische Klinik, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany

    Christoph Langer,  Cornelia Piper,  Jürgen Vogt, Johannes Heintze,  Thomas Butz &  Dieter Horstkotte

  2. Institut für Radiologie, Nuklearmedizin und molekulare Bildgebung, Ruhr-Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany

    Olliver Lindner &  Wolfram Burchert

  3. Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Domagkstraße 17, 48149, Münster, Germany

    C. Kersting

Authors
  1. Christoph Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cornelia Piper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jürgen Vogt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johannes Heintze
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Butz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Olliver Lindner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfram Burchert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Kersting
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dieter Horstkotte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Langer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langer, C., Piper, C., Vogt, J. et al. Atrial fibrillation in carcinoid heart disease. Clin Res Cardiol 96, 114–118 (2007). https://doi.org/10.1007/s00392-006-0463-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-006-0463-y

Keywords

Search

Navigation